Introduction: The objectives of this study were to describe the diagnostic and therapeutic aspects, identify problems and evaluate the survival rate of invasive cervical cancer patients. Patients and method: It was a retrospective descriptive study of 7 years from 1 January 2006 to 31 December 2012. Records of invasive cervical cancer were histologically confirmed. The clinical and therapeutic data collected were transferred to Epi info 7 and SSPS version 18 software with a significance level p < 0.05. The telephone network was used to provide information on the vital condition after confidential agreement. Kaplan Meier was used to assess the overall survival rate. Results: Invasive cancer of the cervix was frequent (58.79%) with an annual median rate of 16.7%, with extremes of 5.8% and 20.6%. 88.70% of the patients was referred from regions of the country (54.02%); the median age was 50 years with extremes of 16 and 84 years and a peak of 29.6% between 35 and 44 years; 76.20% were housewives; uneducated women were about 60.12%; Stage III was about 45.3%. Most of the patients were confirmed histologically after 30 days (68%). The means of treatment were surgery about 91 (29.26%), palliation 75 (24.12%), radiotherapy 59 (18.97%) and chemotherapy 41 (13.18%) with surgery (9, 65%) or radiotherapy (4.82%). The main complication was metrorrhagia, 164 cases (56.55%), with overall survival rate of 51.8% at 2 years and 5.1% at 5 years. Conclusion: Invasive cervical cancer in later stages is treated for low survival in the context of our work. Early detection and treatment of precan- 
Introduction
Cervical cancer is one of the most common gynecologic cancers in the world. It is the second most common cancer of women in the world with 493,000 new cases per year and responsible for more than 275,000 deaths a year, 88% of which occur in low-limited countries [1] . In the United States, where cancer is the second leading cause of death, 12,200 new cases of invasive cervical cancer have been diagnosed and 4210 cases of deaths within Afro and Asian populations [2] . In Latin America and the Caribbean, The mean incidence is 10.4% [3] .
The risk of cervical cancer during life is estimated at 4% in developing countries and less than 1% in industrialized countries [4] .
In Africa, this cancer is at the forefront of female cancers [5] . Its reported standardized incidence in West Africa is 29.3 per 100,000 [6] [7] .
In Guinea, it is the first of the gynecological cancers of Guinean women with an age-standardized incidence of 56.3 per 100,000 [8] . Among them, the most frequent is invasive cervical cancer in the obstetric and gynecologic department at the National Hospital Donka of the Conakry's Teaching Hospital.
The objective of this study is to describe the diagnostic aspects, to identify the difficulties related to the management and to evaluate the outcome of the patients received for invasive cancer of the cervix in our work context.
Materials and Methods
We carried out a quasi-retrospective descriptive study of cases of invasive cervical cancer collected at the Obstetric Gynecology Department of the Donka Na- The median age was 50 years with extremes of 16 and 84 years, with a peak in the age range of 35 -44 years 92 (29.6%), followed by age groups of 55 -64 years
And 45 -54 years in 21.5% respectively. And 22.5% ( Figure 1 ).
Housewives 237 (76.20%) were the most affected socio-professional group followed by the liberal 58 (18.65%). They were uneducated in 60.10% of cases, followed by those having primary education (15.60%) and secondary education of (12.40%) ( Figure 2 ).
Patients used traditional treatment in 80.38% before going to health facilities or having their orientation in the structure health facilities (Text 3).
They were received in the department with clinically advanced lesions in stages II and III in 39.20% and 45.3%, respectively, for a histological confirmation waiting period greater than 30 days in 68% (Table 1 ). In general, overall survival at 2 years was 51.8% and 5.1% at 5 years at 31/12/2012 ( Figure 3 and Figure 4 ).
We did not analyze survival factors such as age, education, parity and clinical stage.
Discussion
Invasive cancer of the cervix was the most important gynecological and mammary cancer with a higher proportion (Text1) than the average of 43.65% in sub-Saharan Africa [9] and 56.3% in Tunisia [10] . The average age at diagnosis of 50 years ± 4 years ( Figure 1 ) is super-imposable at the average ages of 49 -50 reported by Acharki A. et al. [14] in Morocco in 2002 and Monchy D. et al. [15] in Cambodia in 2005. The peak in the age group of 35 -44 years, 92 (29.6%) cases (Figure 1) , is the opposite of 61 -70 years in Tunisia, where in 2004, the mean age was 54 years with 12.5% under 40 years [10] . In other African series, the average age between 43 and 48 years has been reported in Cameroon [10] and Senegal [16] .
The appearance of invasive cervical cancer at a relatively young age in Africa compared to the countries of Europe and America would be linked to the upsurge of risk factors such as early sexual intercourse, multiple sexual partnerships, infections sexually transmitted diseases that expose human papilloma virus (HPV) and HIV, early and forced marriage.
Multiparity, known as a risk factor for cervical cancer, at a very high rate in our series, was certainly linked to forced and unprotected marriages and forced sex at home. This is consistent with the high number of 237 (76.20%) in our series of housewives from disadvantaged socio-economic backgrounds with very limited access to health care due to lack of health information and illiteracy.
Ninety percent of women had no education at all, a rate higher than those of 60.10% and 62% of illiterates respectively in Douala [11] and Abidjan [12] . The predominance of women ( Figure 2 ) is certainly related to the girl's low enrollment rate about 48% in primary school and 11% in secondary school in Guinea in 2005 [17] .
The insidious evolution of the disease, the lack of knowledge of the signs of cancer and the retention of patients in health facilities for irrational and even surgical care, would be linked to the late reference due to a lack of skills within the country where there are only 3 no functional representations of the CERFFO-PCG.
The financial, transport and correspondence problems in Conakry, because the patients reside mostly outside the capital, would contribute to the second delay in diagnosis at a locally advanced clinical stage II and III of 39.20% and 45%, respectively, 3% (Table 2) . We agree with Essomba Biwole M. et al. [11] that the long delay between onset of symptoms and use of care and the absence of a national screening and vaccination policy would explain the high rate of these FIGO Stages.
The promotion of screening for precancerous and cancerous lesions has led to a drastic decline in the rate of advanced stages to 33% in Kenya in 2013 [18] . Twenty-nine, twenty-six percent of the patients had undergone surgery by the enlarged iliac lymphadenectomy (Wertheim surgery) surgery (Table 2 ) for a flat rate of 600,000 GNF (42857,143 CFA or 631,579 €) (2,835,000 GNF or 2984,21 €)
or of medication This rate is far superior to the 5,2% of indications of hysterectomy in Bobo Dioulasso in Burkina Faso in 2011 [21] .
The progression was often accompanied by complications, mainly metrorrhagia, 164 cases (56.55%) with severe anemia (Text 5).
Overall survival at 2 years of 51.8% was lower than the 68% survival reported by Ngomo J et al. [22] . However, at the peak date of 31/12/12 ( Figure 3 and Figure 4 ), overall 5-year survival was 5.1%, significantly lower than 41% found by Acharki A et al. [13] , Would be linked to the diagnosis of cancer at an advanced stage, to the therapeutic and financial difficulties of the patients.
